Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. Issue 1 (24th October 2019) - Bronswijk, Michiel; Moens, Annick; Lenfant, Matthias; Tops, Sophie; Compernolle, Griet; Van Assche, Gert; Vermeire, Séverine; Gils, Ann; Ferrante, Marc